Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel

TE-WGS is a comprehensive approach in personalized oncology, matching TSO500's key biomarker detection capabilities. It uniquely identifies germline variants and genomic instability markers, offering additional clinical actions. Its adaptability and cost-effectiveness underscore its clinical utility, making TE-WGS a valuable tool in personalized cancer treatment.

Authors

Institutions

Publication Details

Journal
Cancer Research and Treatment
Published
2024-09-19
DOI
https://doi.org/10.4143/crt.2024.114
Citations
3
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel

Jong-Yeon Shin, Jin Roh, Jaemo Koo, Minsuk Kwon et al.
3 citations
Cancer Research and Treatment
Cancer Genomics and Diagnostics
0.86
article

Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel

Jong-Yeon Shin, Jin Roh, Jaemo Koo, Minsuk Kwon, Seokhwi Kim, Joonoh Lim, Jung‐Ah Kim, Mi Sun Ahn, Seongyeol Park, Young Seok Ju, İslam Oğuz Tuncay, Ryul Kim, Jeong Seok Lee, Erin Connolly-Strong, Tae‐Hwan Kim, Hyun Woo Lee, Jun Sung Park, Won‐Chul Lee, Sangmoon Lee, Jang‐Hee Kim, Hansol Park, Yong Won Choi, Brian Baek-Lok Oh
article en
3 citations

Abstract

TE-WGS is a comprehensive approach in personalized oncology, matching TSO500's key biomarker detection capabilities. It uniquely identifies germline variants and genomic instability markers, offering additional clinical actions. Its adaptability and cost-effectiveness underscore its clinical utility, making TE-WGS a valuable tool in personalized cancer treatment.

Cancer Research and TreatmentVol. 57(2)
Samsung Medical Center (KR), Ajou University (KR), Sungkyunkwan University (KR)
National Research Foundation, Korea Health Industry Development Institute, National Research Foundation of Korea, Ministry of Science and ICT, South Korea
Zero hunger
Openalex Percentile: Top 26%
Cancer Genomics and Diagnostics
0.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.